CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

HYDROCORTISONE VALERATE

· ingredient hydrocortisoneCorticosteroids· HYDROCORTISONE VALERATE 2 mg/g
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$0.28260
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per GM — the trend nobody else shows. 6 weeks.

2025-12-172026-05-20

Same-ingredient options by acquisition cost

Other hydrocortisone products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.

ProductNADAC / GMvs this
Absolut Skin Corticosoothe Anti-Itch$0.06272−$0.21990
Hydrocortisone$0.07424−$0.20840
anti itch$0.07838−$0.20420
ANTI-ITCH FEMININE CARE$0.08285−$0.19970
Hydrocortisone$0.10310−$0.17950
Hydrocortisone Rectal Suspension (Retention)$0.16179−$0.12080
CORTEF$0.19405−$0.08860
hydrocortisone$0.22379−$0.05880

Medicare Part D coverage · CY2026

On 223 plan formularies · typical tier 2
Prior auth 0% · Step therapy 0% · Quantity limit 46% of formularies

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.